Jan 1, 1995

In vitro and in vivo activity of DQ-2556, a new cephalosporin

Chemotherapy
Y IshidaS Goto

Abstract

The antibacterial activity of DQ-2556, a new cephalosporin, was compared with that of cefepime, cefpirome, and other antibiotics. DQ-2556 was more active than cefepime and less active than cefpirome against gram-positive bacteria. DQ-2556 was the most active compound against most members of the Enterobacteriaceae, such as Escherichia coli, Klebsiella, Proteus, Salmonella spp., and Shigella spp., and Haemophilus influenzae and Neisseria gonorrhoeae. In vivo, treatment with DQ-2556 was as or more efficacious than that with reference compounds in both systemic and respiratory tract infections in mice. DQ-2556 achieved higher concentrations than cefepime and cefpirome in lungs and kidney of mice.

  • References
  • Citations8

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations8

Citations

Mentioned in this Paper

Gram-Positive Bacteria
Enterobacteriaceae
Haemophilus influenzae
Meningitis, Haemophilus
Lung
DQ 2556
Proteus
Cephalosporins
Salmonella
Respiratory Tract Infections

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.